Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy
Year: 2019
Type: review
Source: Journal of Cellular Physiology
DOI: 10.1002/jcp.28967
Institutions: Iranshahr University, Shiraz University of Medical Sciences, Kashan University of Medical Sciences, Tabriz University of Medical Sciences, Birjand University of Medical Sciences, University of Larestan, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Golestan University of Medical Sciences, Bam University of Medical Sciences, Shahrekord University of Medical Sciences
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2950613960
